“A new study has found that the use of weight-adjusted hydroxychloroquine (HCQ) and azithromycin (AZM) improved the survival of ventilated COVID-19 patients by nearly 200 percent.”

Note that the HCQ and AZM dosing is described as cumulative and not individual doses!

https://www.zerohedge.com/covid-19/hydroxychloroquine-azithromycin-boosted-survival-ventilated-covid-19-patients-200-new